Physician profile
Andre H Johnson
NPI 1861616922
$12,236.30
in general payments reported to CMS, 2019-2025
14 companies · $3,130 in 2025
The $3,130 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,981 · 2020: $673 · 2021: $1,370 · 2022: $362 · 2023: $4,438 · 2024: $282 · 2025: $3,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $5,500 · Food and Beverage: $1,535 · Travel and Lodging: $816.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $5,500.00 |
| Food and Beverage | $1,534.87 |
| Travel and Lodging | $816.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,308.42 | 2019-2025 | |
| Prodigy Surgical Distribution, INC. | $2,620.73 | 2020-2025 | |
| Zimmer Biomet Holdings, INC. | $739.05 | 2019-2024 | Gel-One Cross-Linked Hyaluronate, Persona |
| Stryker Corporation | $387.76 | 2019-2025 | Gamma, 1788, Inspace |
| Ferring Pharmaceuticals INC. | $367.97 | 2023-2025 | Euflexxa |
| Arthrosurface Incorporated | $285.92 | 2019-2020 | |
| Depuy Synthes Sales INC. | $172.38 | 2022-2025 | Inhance |
| Encore Medical, LP | $170.10 | 2021 | |
| Integra Lifesciences Corporation | $82.22 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $22.88 | 2025 | |
| Convatec INC. | $22.66 | 2023 | |
| Heraeus Medical, LLC. | $20.65 | 2024 | |
| Olympus America INC. | $18.72 | 2023 | |
| Fidia Pharma USA INC. | $16.84 | 2025 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.